Literature DB >> 17593045

Radioguided localization of clinically occult breast lesions (ROLL): a pilot study.

Heriberto Medina-Franco1, Leonardo Abarca-Pérez, José L Ulloa-Gómez, Cecilia Romero.   

Abstract

Management of nonpalpable breast lesions requiring pathologic diagnosis has been with wire localization during the last few decades. Recently, radioguided localization (ROLL) became an alternative for this type of lesions. The objective of the present study was to evaluate the feasibility of this technique in a tertiary referral center in Mexico City. Consecutive patients requiring pathologic diagnosis from a nonpalpable breast lesion were included in the present study. On the same day of operation, all patients were injected with particles of human serum albumin. Localization of the lesion was performed in the operation theater with the aid of a hand-held gamma-probe. All lesions were identified in a control x-ray of the surgical specimen. Demographic, clinical, surgical and pathologic data were recorded. Forty patients with a mean age of 56.8 +/- 7.8 years were included. In 39 of the 40 patients (97.5%) the "hot spot" was identified easily. In all patients, the area of maximum radioactivity corresponded to the site of the lesion. Imaging confirmation of the lesion in the surgical specimen was done during the first excision in 37 patients (92.5%). In the remaining cases (7.5%), a wider excision was performed during the same procedure, finding the suspected lesion in all cases. Diagnosis of cancer was made in seven patients, (17.5%). There were no significant surgical complications. Our data suggest that ROLL offer a simple and reliable method to localize occult breast lesions, allowing complete removal of the lesion in 100% of the patients. Because of the small quantity of radioactivity, the procedure is safe for both patients and the medical staff, producing less discomfort in patients than wire localization.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17593045     DOI: 10.1111/j.1524-4741.2007.00448.x

Source DB:  PubMed          Journal:  Breast J        ISSN: 1075-122X            Impact factor:   2.431


  6 in total

1.  Radio-guided occult lesion localisation for breast lesions under computer-aided MRI guidance: the first experience and initial results.

Authors:  M H Yilmaz; F Kilic; G E Icten; F Aydogan; V Ozben; M Halac; D C Olgun; E Gazioglu; V Celik; C Uras; Z A Altug
Journal:  Br J Radiol       Date:  2011-10-18       Impact factor: 3.039

2.  Incidence and risk factors of the intraoperative localization failure of nonpalpable breast lesions by radio-guided occult lesion localization: a retrospective analysis of 579 cases.

Authors:  Sergio Bernardi; Serena Bertozzi; Ambrogio P Londero; Giuliana Gentile; Francesco Giacomuzzi; Arnalda Carbone
Journal:  World J Surg       Date:  2012-08       Impact factor: 3.352

Review 3.  A comprehensive overview of radioguided surgery using gamma detection probe technology.

Authors:  Stephen P Povoski; Ryan L Neff; Cathy M Mojzisik; David M O'Malley; George H Hinkle; Nathan C Hall; Douglas A Murrey; Michael V Knopp; Edward W Martin
Journal:  World J Surg Oncol       Date:  2009-01-27       Impact factor: 2.754

4.  Surgical outcomes of localization using indocyanine green fluorescence in breast conserving surgery: a prospective study.

Authors:  Eun-Gyeong Lee; Seok-Ki Kim; Jai Hong Han; Dong-Eun Lee; So-Youn Jung; Seeyoun Lee
Journal:  Sci Rep       Date:  2021-05-11       Impact factor: 4.379

5.  Surgical outcome of patients with core-biopsy-proven nonpalpable breast carcinoma: a large cohort follow-up study.

Authors:  S van Esser; N H G M Peters; M A A J van den Bosch; W P Th M Mali; P H M Peeters; I H M Borel Rinkes; R van Hillegersberg
Journal:  Ann Surg Oncol       Date:  2009-05-13       Impact factor: 5.344

6.  The efficacy of 'radio guided occult lesion localization' (ROLL) versus 'wire-guided localization' (WGL) in breast conserving surgery for non-palpable breast cancer: a randomized clinical trial - ROLL study.

Authors:  Stijn van Esser; Monique G G Hobbelink; Petra H M Peeters; Erik Buskens; Iris M van der Ploeg; Willem P T H M Mali; Inne H M Borel Rinkes; Richard van Hillegersberg
Journal:  BMC Surg       Date:  2008-05-21       Impact factor: 2.102

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.